Belmont, CA, United States of America

Robert Ronald Milburn

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 10.3

ph-index = 2

Forward Citations = 36(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2016)
  • Belmont, CA (US) (2022 - 2023)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Robert Ronald Milburn

Introduction

Robert Ronald Milburn is a notable inventor based in Belmont, CA (US). He has made significant contributions to the field of chemistry, particularly in the development of Mcl-1 inhibitors. With a total of 5 patents to his name, Milburn's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Milburn's latest patents include innovative processes for synthesizing macrocyclic Mcl-1 inhibitor intermediates. One of his key patents details the ring closing synthesis of these inhibitors, specifically focusing on compound F and its derivatives. Additionally, he has developed processes for synthesizing sulfonamide intermediates, which are crucial for the preparation of Mcl-1 inhibitors, including compounds A1 and A2.

Career Highlights

Throughout his career, Milburn has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Gilead Sciences, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Milburn has collaborated with several talented individuals in his field, including Jason S. Tedrow and Pavel Robertovich Badalov. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Robert Ronald Milburn's contributions to the field of chemistry and his innovative patents in Mcl-1 inhibitors highlight his importance as an inventor. His work continues to influence the pharmaceutical industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…